New Cholesterol Guidelines: Screening, Risk, and Targets

Big changes in cholesterol guidelines will spark conversations about managing patients withOUT atherosclerotic cardiovascular disease (ASCVD).

Be ready to discuss earlier screening and treatment...LDL-C targets...and the role of CV risk markers (lipoprotein(a), etc).

Screening. Check a lipid profile (fasting or nonfasting) for patients between ages 9 and 11 years...and again at 19 years.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote